Table 1. Core indicators for measuring progress towards the SDG targets and related 2020 targets.

Indicator	WHO European Region Action Plan Target for 2020	WHO GHSS Target for 2020
Prevention
HBV: Coverage with three doses of the HBV vaccine among 1 year olds in countries that implement universal childhood HBV vaccination	95% vaccinated	90% vaccinated
HCV: Harm reduction for people who inject drugs (PWID) Coverage of clean needle and syringe programmes (NSP) Coverage of opioid substitution therapy (OST)	200 syringes distributed per PWID per year; 40% of opioid dependent PWID receiving opioid substitution therapy	200 sterile needles and syringes provided per PWID per year
The continuum of care for HBV and HCV
Percent of those with chronic infection tested and aware of their diagnosis	50% diagnosed*	30% diagnosed
Percent of those aware of their HBV diagnosis on treatment, among those eligible for treatment** Percent of those aware of their HCV diagnosis started on treatment	75% on treatment/started on treatment***	5 million people receiving HBV treatment 3 million people have received HCV treatment
Percent of those on treatment achieving viral suppression (HBV) or of those on treatment achieving sustained viral response (HCV)	90% achieve viral suppression (HBV) or sustained viral response (HCV)	NA

HBV- hepatitis B virus; HCV–hepatitis C virus; PWID–people who injects drugs; SDG–sustainable development goals.

*Diagnosed with chronic hepatitis (HBV: HBsAg positive; HCV: PCR positive).

** According to European Association for the Study of the Liver (EASL) guidelines.

***Started on treatment during the reporting year.

NB: WHO target around OST does not further define measurement of OST coverage.